SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010931
Filing Date
2019-11-13
Accepted
2019-11-13 16:03:15
Documents
79
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20190930x10q.htm 10-Q 2176460
2 EX-31.1 aplt-20190930ex311a59890.htm EX-31.1 11583
3 EX-31.2 aplt-20190930ex3123974fc.htm EX-31.2 11966
4 EX-32.1 aplt-20190930ex3210ee7d6.htm EX-32.1 10184
  Complete submission text file 0001558370-19-010931.txt   7145105

Data Files

Seq Description Document Type Size
5 EX-101.INS aplt-20190930.xml EX-101.INS 1256122
6 EX-101.SCH aplt-20190930.xsd EX-101.SCH 58302
7 EX-101.CAL aplt-20190930_cal.xml EX-101.CAL 35535
8 EX-101.DEF aplt-20190930_def.xml EX-101.DEF 252782
9 EX-101.LAB aplt-20190930_lab.xml EX-101.LAB 483701
10 EX-101.PRE aplt-20190930_pre.xml EX-101.PRE 413331
Mailing Address 340 MADISON AVENUE 19TH FLOOR NEW YORK NY 10173
Business Address 340 MADISON AVENUE 19TH FLOOR NEW YORK NY 10173 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 191213902
SIC: 2834 Pharmaceutical Preparations